Pre-earnings options volume in Actinium Pharmaceuticals is normal with calls leading puts 7:2. Implied volatility suggests the market is anticipating a move near 7.4%, or 86c, after results are released. Median move over the past eight quarters is 3.0%.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on ATNM:
- Biotech Alert: Searches spiking for these stocks today
- Actinium Pharmaceuticals appoints Caroline Yarbrough as Chief Commercial Office
- Actinium Pharmaceuticals price target raised to $35 from $25 at Maxim
- Actinium Pharmaceuticals price target raised to $18 from $16 at B. Riley
- Actinium Up After Positive Topline Clinical Data